These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 8473834)

  • 1. The 11 beta-hydroxysteroid dehydrogenase inhibitor glycyrrhetinic acid affects corticosteroid feedback regulation of hypothalamic corticotrophin-releasing peptides in rats.
    Seckl JR; Dow RC; Low SC; Edwards CR; Fink G
    J Endocrinol; 1993 Mar; 136(3):471-7. PubMed ID: 8473834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attenuation of hypothalamic-pituitary-adrenal axis stress responses in late pregnancy: changes in feedforward and feedback mechanisms.
    Johnstone HA; Wigger A; Douglas AJ; Neumann ID; Landgraf R; Seckl JR; Russell JA
    J Neuroendocrinol; 2000 Aug; 12(8):811-22. PubMed ID: 10929094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effect of adrenocorticosteroids on 11 beta-hydroxysteroid dehydrogenase bioactivity at the anterior pituitary and hypothalamus in rats.
    Idrus RB; Mohamad NB; Morat PB; Saim A; Abdul Kadir KB
    Steroids; 1996 Aug; 61(8):448-52. PubMed ID: 8870163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycyrrhetinic acid, an inhibitor of 11 beta-hydroxysteroid dehydrogenase, alters local cerebral glucose utilization in vivo.
    Seckl JR; Kelly PA; Sharkey J
    J Steroid Biochem Mol Biol; 1991 Nov; 39(5A):777-9. PubMed ID: 1958512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 11 beta-hydroxysteroid dehydrogenase bioactivity and messenger RNA expression in rat forebrain: localization in hypothalamus, hippocampus, and cortex.
    Moisan MP; Seckl JR; Edwards CR
    Endocrinology; 1990 Sep; 127(3):1450-5. PubMed ID: 2387261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 11 beta-hydroxysteroid dehydrogenase in vascular smooth muscle and heart: implications for cardiovascular responses to glucocorticoids.
    Walker BR; Yau JL; Brett LP; Seckl JR; Monder C; Williams BC; Edwards CR
    Endocrinology; 1991 Dec; 129(6):3305-12. PubMed ID: 1954906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corticotrophin-releasing peptides in rat hypophysial portal blood after paraventricular lesions: a marked reduction in the concentration of corticotrophin-releasing factor-41, but no change in vasopressin.
    Antoni FA; Fink G; Sheward WJ
    J Endocrinol; 1990 May; 125(2):175-83. PubMed ID: 2373973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased expression of corticotropin-releasing hormone and vasopressin messenger ribonucleic acid (mRNA) in the hypothalamic paraventricular nucleus during repeated stress: association with reduction in glucocorticoid receptor mRNA levels.
    Makino S; Smith MA; Gold PW
    Endocrinology; 1995 Aug; 136(8):3299-309. PubMed ID: 7628364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ontogeny of 11 beta-hydroxysteroid dehydrogenase in rat brain and kidney.
    Moisan MP; Edwards CR; Seckl JR
    Endocrinology; 1992 Jan; 130(1):400-4. PubMed ID: 1727713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucocorticoids regulate hippocampal 11 beta-hydroxysteroid dehydrogenase activity and gene expression in vivo in the rat.
    Low SC; Moisan MP; Noble JM; Edwards CR; Seckl JR
    J Neuroendocrinol; 1994 Jun; 6(3):285-90. PubMed ID: 7920594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in the expression of corticotrophin-releasing hormone, mineralocorticoid receptor and glucocorticoid receptor mRNAs in the hypothalamic paraventricular nucleus induced by fornix transection and adrenalectomy.
    Han F; Ozawa H; Matsuda KI; Lu H; De Kloet ER; Kawata M
    J Neuroendocrinol; 2007 Apr; 19(4):229-38. PubMed ID: 17244200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intact catecholamine inputs to the forebrain are required for appropriate regulation of corticotrophin-releasing hormone and vasopressin gene expression by corticosterone in the rat paraventricular nucleus.
    Kaminski KL; Watts AG
    J Neuroendocrinol; 2012 Dec; 24(12):1517-26. PubMed ID: 22831701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Licorice inhibits 11 beta-hydroxysteroid dehydrogenase messenger ribonucleic acid levels and potentiates glucocorticoid hormone action.
    Whorwood CB; Sheppard MC; Stewart PM
    Endocrinology; 1993 Jun; 132(6):2287-92. PubMed ID: 8504732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of basal corticotropin-releasing hormone and arginine vasopressin messenger ribonucleic acid expression in the paraventricular nucleus: effects of selective hypothalamic deafferentations.
    Herman JP; Wiegand SJ; Watson SJ
    Endocrinology; 1990 Nov; 127(5):2408-17. PubMed ID: 2171915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Possible endogenous regulators of steroid inactivating enzymes and glucocorticoid-induced Na+ retention.
    Latif SA; Hartman LR; Souness GW; Morris DJ
    Steroids; 1994 Jun; 59(6):352-6. PubMed ID: 7940612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Consequences of prenatal morphine exposure on the hypothalamo-pituitary-adrenal axis in the newborn rat: effect of maternal adrenalectomy.
    Lesage J; Grino M; Bernet F; Dutriez-Casteloot I; Montel V; Dupouy JP
    J Neuroendocrinol; 1998 May; 10(5):331-42. PubMed ID: 9663647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of 11 beta-hydroxysteroid dehydrogenase by sex steroids in vivo: further evidence for the existence of a second dehydrogenase in rat kidney.
    Low SC; Assaad SN; Rajan V; Chapman KE; Edwards CR; Seckl JR
    J Endocrinol; 1993 Oct; 139(1):27-35. PubMed ID: 8254291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucocorticoid implants around the hypothalamic paraventricular nucleus prevent the increase of corticotropin-releasing factor and arginine vasopressin immunostaining induced by adrenalectomy.
    Kovács K; Kiss JZ; Makara GB
    Neuroendocrinology; 1986; 44(2):229-34. PubMed ID: 3540700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucocorticosteroids up-regulate the expression of cholecystokinin mRNA in the rat paraventricular nucleus.
    Cournil I; Lafon P; Juaneda C; Ciofi P; Fournier MC; Sarrieau A; Tramu G
    Brain Res; 2000 Sep; 877(2):412-23. PubMed ID: 10986362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic all-trans retinoic acid administration induces CRF over-expression accompanied by AVP up-regulation and multiple CRF-controlling receptors disturbance in the hypothalamus of rats.
    Cai L; Li R; Zhou JN
    Brain Res; 2015 Mar; 1601():1-7. PubMed ID: 25578258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.